RBC Capital lowered the firm’s price target on Acadia Healthcare (ACHC) to $19 from $22 and keeps an Outperform rating on the shares. The firm cites the company having disappointed with yet another downward guidance revision as Acadia underestimated its expected 2025 PLGL – professional and general liability – expenses, the analyst tells investors in a research note, adding that the management also expects liability expenses to remain elevated through 2026.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $17 from $22 at Cantor Fitzgerald
- Acadia Healthcare price target lowered to $24 from $28 at UBS
- Leerink downgrades Acadia Healthcare on ‘real risk’ of legal liabilities
- Acadia Healthcare price target lowered to $25 from $30 at KeyBanc
- BofA downgrades Acadia Healthcare to Underperform after another guidance cut